Zhenheng Wu
Papers
1
Total Citations
2
H-Index
1
About
Dr. Zhenheng Wu is a leading surgical oncologist whose research focuses on optimizing minimally invasive approaches for hepatocellular carcinoma (HCC) treatment. His major contributions center on comparative effectiveness research evaluating robotic-assisted, laparoscopic, and open liver resection techniques for patients with BCLC stage 0/A HCC. In his landmark 2025 nationwide cohort study, Dr. Wu systematically analyzed clinical and economic outcomes across these three surgical modalities, providing crucial evidence to guide surgical decision-making in early-stage liver cancer. This work, already garnering 2 citations shortly after publication, addresses the longstanding debate about optimal surgical approaches by examining both patient outcomes and healthcare costs. Dr. Wu’s research is particularly notable for its real-world, population-level perspective, offering insights that directly inform clinical practice and health policy. His findings help surgeons and patients weigh the benefits of robotic and laparoscopic techniques—such as reduced recovery times—against traditional open surgery, while also considering economic implications for healthcare systems. Through his rigorous comparative analyses, Dr. Wu continues to shape the evolution of liver cancer surgery toward more personalized, evidence-based treatment pathways.
Research Focus
Key Achievements
Top Papers
- 1